Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures

Vascular access site complications (ASC) are among the most frequent complications of percutaneous cardiovascular procedures (PCP) and are associated with adverse outcome and high resources utilization. In this prospective study, we investigated patients with postprocedural clinical suspicion of ASC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Johanna Hetrodt, Christiane Engelbertz, Katrin Gebauer, Jacqueline Stella, Matthias Meyborg, Eva Freisinger, Holger Reinecke, Nasser Malyar
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/6a852db884c84db5b7ec0d0e7034e39f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6a852db884c84db5b7ec0d0e7034e39f
record_format dspace
spelling oai:doaj.org-article:6a852db884c84db5b7ec0d0e7034e39f2021-11-25T18:00:12ZAccess Site Related Vascular Complications following Percutaneous Cardiovascular Procedures10.3390/jcdd81101362308-3425https://doaj.org/article/6a852db884c84db5b7ec0d0e7034e39f2021-10-01T00:00:00Zhttps://www.mdpi.com/2308-3425/8/11/136https://doaj.org/toc/2308-3425Vascular access site complications (ASC) are among the most frequent complications of percutaneous cardiovascular procedures (PCP) and are associated with adverse outcome and high resources utilization. In this prospective study, we investigated patients with postprocedural clinical suspicion of ASC evaluated by duplex ultrasound (DUS) for the presence of ASC. We assessed the incidence, in-hospital outcome, treatment of complications and predictors for ASC. Overall, 12,901 patients underwent PCP during a 40 months period. Of those, 2890 (22.4%) patients had postprocedural clinical symptoms of ASC and were evaluated using DUS. An ASC was found in 206 of the DUS examined patients (corresponding to 7.1% of the 2890 DUS examined patients). In 6.7% of all valvular/TAVI procedures, an ASC was documented, while coronary, electrophysiological and peripheral PCP had a comparable and low rate of complications (1.2–1.5%). Pseudoaneurysm (PSA) was the most frequent ASC (67.5%), followed by arteriovenous fistula (13.1%), hematoma (7.8%) and others (11.7%). Of all PSA, 84 (60.4%) were treated surgically, 44 (31.6%) by manual compression and 11 (7.9%) conservatively. Three (0.02%) patients died due to hemorrhagic shock. In conclusion, femoral ASC are rare in the current era of PCP with PSA being the leading type of ASC. Nonetheless, patients with predisposing risk factors and postprocedural suspicious clinical findings should undergo a DUS to early detect and mitigate ASC-associated outcome.Johanna HetrodtChristiane EngelbertzKatrin GebauerJacqueline StellaMatthias MeyborgEva FreisingerHolger ReineckeNasser MalyarMDPI AGarticlepercutaneous cardiovascular proceduresaccess site complicationsfemoral accesspseudoaneurysmoutcomeDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of Cardiovascular Development and Disease, Vol 8, Iss 136, p 136 (2021)
institution DOAJ
collection DOAJ
language EN
topic percutaneous cardiovascular procedures
access site complications
femoral access
pseudoaneurysm
outcome
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle percutaneous cardiovascular procedures
access site complications
femoral access
pseudoaneurysm
outcome
Diseases of the circulatory (Cardiovascular) system
RC666-701
Johanna Hetrodt
Christiane Engelbertz
Katrin Gebauer
Jacqueline Stella
Matthias Meyborg
Eva Freisinger
Holger Reinecke
Nasser Malyar
Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures
description Vascular access site complications (ASC) are among the most frequent complications of percutaneous cardiovascular procedures (PCP) and are associated with adverse outcome and high resources utilization. In this prospective study, we investigated patients with postprocedural clinical suspicion of ASC evaluated by duplex ultrasound (DUS) for the presence of ASC. We assessed the incidence, in-hospital outcome, treatment of complications and predictors for ASC. Overall, 12,901 patients underwent PCP during a 40 months period. Of those, 2890 (22.4%) patients had postprocedural clinical symptoms of ASC and were evaluated using DUS. An ASC was found in 206 of the DUS examined patients (corresponding to 7.1% of the 2890 DUS examined patients). In 6.7% of all valvular/TAVI procedures, an ASC was documented, while coronary, electrophysiological and peripheral PCP had a comparable and low rate of complications (1.2–1.5%). Pseudoaneurysm (PSA) was the most frequent ASC (67.5%), followed by arteriovenous fistula (13.1%), hematoma (7.8%) and others (11.7%). Of all PSA, 84 (60.4%) were treated surgically, 44 (31.6%) by manual compression and 11 (7.9%) conservatively. Three (0.02%) patients died due to hemorrhagic shock. In conclusion, femoral ASC are rare in the current era of PCP with PSA being the leading type of ASC. Nonetheless, patients with predisposing risk factors and postprocedural suspicious clinical findings should undergo a DUS to early detect and mitigate ASC-associated outcome.
format article
author Johanna Hetrodt
Christiane Engelbertz
Katrin Gebauer
Jacqueline Stella
Matthias Meyborg
Eva Freisinger
Holger Reinecke
Nasser Malyar
author_facet Johanna Hetrodt
Christiane Engelbertz
Katrin Gebauer
Jacqueline Stella
Matthias Meyborg
Eva Freisinger
Holger Reinecke
Nasser Malyar
author_sort Johanna Hetrodt
title Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures
title_short Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures
title_full Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures
title_fullStr Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures
title_full_unstemmed Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures
title_sort access site related vascular complications following percutaneous cardiovascular procedures
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/6a852db884c84db5b7ec0d0e7034e39f
work_keys_str_mv AT johannahetrodt accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures
AT christianeengelbertz accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures
AT katringebauer accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures
AT jacquelinestella accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures
AT matthiasmeyborg accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures
AT evafreisinger accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures
AT holgerreinecke accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures
AT nassermalyar accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures
_version_ 1718411747942989824